About Orphanbiotec

About company

Orphanbiotec works on the development and implementation of new medications for Rare Diseases. Their nature based pharmaceutical solutions create affordable therapies for Rare Diseases in a sustainable and profitable manner through the repositioning of approved substances. The company was founded in January 2009. Orphanbiotec AG is a Swiss Start-up company, which works in a unique hybrid partnership with the charitable Foundation Orphanhealthcare. Orphanbiotec engages in delivering sustainable, financial and social impact to patients & investors.